Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134683) titled 'A prospective, single-center, open-label randomized controlled trial protocol for magnesium supplementation in peritoneal dialysis patients' on Oct. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Air Force Medical University
Condition:
Maintenance peritoneal dialysis complicated with hypomagnesemia
Intervention:
The low-magnesium intervention group:For this group of subjects, in addition to the conventional peritoneal dialysis treatment, they were given oral iraven brand magnesium tablets for magnesium supplementation intervention. The drugs wer...